Additional information
| Active substance | Mometasone |
|---|---|
| Chemical name | (11ОІ,16О±)-9,21-Dichloro-17-((2-furanylcarbonyl)oxy)-11-hydroxy-16-methylpregna-1,4-diene-3,20-dione |
| Side effects | Nasal irritation and burning, headache, pharyngitis, increased risk of infection, potential systemic effects with long-term use |
| Effects | Reduces inflammation, decreases swelling and itching |
| Dosage (sports) | Not applicable as not typically used in sports settings |
| Dosage (medical) | Typically 50 mcg per spray for nasal sprays, 0.1% cream or ointment applied once daily |
| Half-life | 5.8 hours |
| Main action | Anti-inflammatory |
| Substance class | Corticosteroid |
| Formula | C27H30Cl2O6 |
| Storage conditions | Store at controlled room temperature, away from light and moisture |
| Trade name | Nasonex, Elocon |
| Blood pressure | Typically has no effect on blood pressure |
| Also known as | Mometasone |
| Strength | 50mcg |
| Lab Test | Not typically monitored by specific lab tests in clinical settings |
| Hepatotoxicity | Low |
| Water Retention | Minimal |
| Use in sports | Not commonly used, potential for misuse as anti-inflammatory |
| Manufacturer | Cipla Ltd. |
| Packing | 1 bottle/pack |
Reviews
There are no reviews yet.